ALPHA LIPOIC ACID TABLETS
Natural health product licensed in Canada
- Licence holder
- Vitaleyoumi Wellness Inc.
- NPN or DIN-HM
- 80141645
- Status
- Active licence
- Licence date
- 6 June 2025
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Morus alba Source : Morus alba - feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 150 mg | 15 mg | Not calculated |
| Niacine Source : Niacinamide | 1.5 mg | Not calculated |
| Paullinia cupana Source : Paullinia cupana - Graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 40 mg Potency : 10 % Caffeine | 10 mg | Not calculated |
| Phaseolus vulgaris Source : Phaseolus vulgaris - Graine Extract : Matériel brut sec Dry plant equivalent : 3,000 mg Potency : 750 AAIU Alpha-Amylase Inhibitors | 250 mg | Not calculated |
| Cinnamomum aromaticum Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 150 mg | 15 mg | Not calculated |
| Ganoderma lucidum Source : Ganoderma lucidum - mycelia | 5 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Potency : 80 % Oligomeric proanthocyanidins | 10 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium, Carboxyméthyl amidon de sodium, Sorbitol, Dioxyde de titane, Oxyde de fer rouge, Hydroxypropyl méthylcellulose, Poly(éthylène glycol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the (enzymatic) digestion of carbohydrates and improve (postprandial) glucose metabolism (within two hours after a meal). Helps to promote healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80141645
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.